enquires@avipep.com.au

Pipeline

Avipep is developing improved diagnostic and therapeutic products to address unmet clinical treatments for prostate, colorectal and breast cancers.

Our product pipeline focuses on clinically-validated targets that can deliver to a large target population.

Research and Development Pipeline

Research and Development Pipeline
Design/ Engineer Optimize/ Selection In vitro stability Proof of Concept In vivo Proof of Concept cGMP process development Safety/ Toxicology IND Phase I/II Out-license Partner
Detail AVP4 AVP5 AVP6 AVP7
Antigen type Call surface glycoprotein Cell surface protein Surface bound enzyme cell surface receptor
Indications CRC
Gastric
Breast
Prostate
Ovarian
NHL
Rheumatoid Arthritis
System Lupus Erythematosus
Prostate
Neovasculature
Breast, Ovarian
Human validation of targets Yes Yes Yes Yes
avi-pep
Interface Design by Think Soda